PAS
STRO icon

Point72 Asia (Singapore)’s Sutro Biopharma STRO Stock Holding History

Point72 Asia (Singapore)’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$26.9K Sell
3,103
-3,004
-49% -$25.6K ﹤0.01% 659
2025
Q2 		$43.6K Buy
+6,107
New +$49.9K 0.01% 618

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Point72 Asia (Singapore)'s STRO Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Sutro Biopharma (STRO) stake by 49% in Q3 2025, selling an estimated $25.6K and leaving 3,103 shares worth $26.9K. The position accounts for ﹤0.01% of the portfolio, ranked #659.

Point72 Asia (Singapore) first reported a position in STRO in Q2 2025 and has held it in 2 quarters since. The position peaked at $43.6K in Q2 2025. 87 funds tracked by Wall St. Rank hold STRO as of Q3 2025.

  • Point72 Asia (Singapore) held 3,103 shares of Sutro Biopharma worth $26.9K as of Q3 2025.
  • Point72 Asia (Singapore) sold 3,004 Sutro Biopharma shares in Q3 2025, an estimated $25.6K.
  • Sutro Biopharma made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #659 holding.
  • Point72 Asia (Singapore) first reported a position in Sutro Biopharma in Q2 2025 and has held it in 2 quarters since.
  • Point72 Asia (Singapore)'s Sutro Biopharma position peaked at $43.6K in Q2 2025.
  • 87 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.